SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-23-000065
Filing Date
2023-05-04
Accepted
2023-05-04 09:55:44
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20230331.htm   iXBRL 10-Q 1339650
2 EX-10.1 exhibit101.htm EX-10.1 83474
3 EX-31.1 exhibit31-1x03x31x23.htm EX-31.1 9801
4 EX-31.2 exhibit31-2x03x31x23.htm EX-31.2 9812
5 EX-32.1 exhibit32-1x03x31x23.htm EX-32.1 4795
6 EX-32.2 exhibit32-2x03x31x23.htm EX-32.2 4790
  Complete submission text file 0001439222-23-000065.txt   5764935

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20230331.xsd EX-101.SCH 38576
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20230331_cal.xml EX-101.CAL 69580
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20230331_def.xml EX-101.DEF 146858
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20230331_lab.xml EX-101.LAB 478925
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20230331_pre.xml EX-101.PRE 314210
60 EXTRACTED XBRL INSTANCE DOCUMENT agio-20230331_htm.xml XML 858071
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 23886903
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences